Skip to content
2000
image of Next-Generation Probiotics in Allergy Therapy: Scientific Evidence and Clinical Applications

Abstract

The global increase in allergic diseases, such as atopic dermatitis, allergic rhinitis, asthma, and food allergies, has become a major public health issue. These diseases typically involve immune dysregulation, including a Th1/Th2 imbalance, increased IgE levels, regulatory T cell (Treg) dysfunction, and epithelial barrier dysfunction. New research has recognised an important role for the gut and mucosal microbiome in regulating immune responses and has prompted interest in the therapeutic utility of probiotics. Probiotics are live microbes that, when given in adequate amounts, confer health benefits, generally such as immunomodulation or restoration of gut barrier function. Traditional probiotics (, Lactobacillus and Bifidobacterium species) reduce allergic inflammation through promotion of Treg differentiation, increases in anti-inflammatory cytokines (., IL-10), suppression of Th2 cytokines (., IL-4), and modification of IFNγ. Traditional probiotics also support mucosal barrier function and restore microbial composition by producing short-chain fatty acids (SCFAs), like butyrate, which act directly on G-protein-coupled receptors and histone deacetylases to suppress inflammation. Next-generation probiotics (NGPs), such as Akkermansia muciniphila, Faecalibacterium prausnitzii, Bacteroides fragilis, and some clusters of Clostridia, can provide more targeted effects. These NGPs can secrete anti-inflammatory metabolite compounds, such as polysaccharide A (PSA), which modulate dendritic cells and increase Treg activity, and can promote mucin production to improve gut barrier function. Overall, there are key issues with strain specificity, dose, safety in immunocompromised individuals, and possible regulatory classification issues. Future opportunities may include precision microbiome profiling, synthetic biology, and artificial intelligence-driven strain discovery to develop personalised approaches to allergy immunotherapy.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/aiaamc/10.2174/0118715230407403251105101126
2025-12-04
2026-01-31

  • From This Site

    /content/journals/aiaamc/10.2174/0118715230407403251105101126
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. Chang Y. Zhang Y. Bai Y. Lin R. Qi Y. Li M. The correlation between tic disorders and allergic conditions in children: A systematic review and meta-analysis of observational studies. Front Pediatr. 2023 11 1064001 10.3389/fped.2023.1064001 37020645
    [Google Scholar]
  2. Gutowska-Ślesik J. Samoliński B. Krzych-Fałta E. The increase in allergic conditions based on a review of literature. Postepy Dermatol. Alergol. 2023 40 1 1 7 10.5114/ada.2022.119009 36909919
    [Google Scholar]
  3. Pandya A. Adah E. Jones B. Chevalier R. The evolving landscape of immunotherapy for the treatment of allergic conditions. Clin. Transl. Sci. 2023 16 8 1294 1308 10.1111/cts.13546 37170653
    [Google Scholar]
  4. Kronzer V.L. Westerlind H. Alfredsson L. Crowson C.S. Klareskog L. Holmqvist M. Askling J. Allergic conditions and risk of rheumatoid arthritis: A Swedish case–control study. RMD Open 2022 8 1 e002018 10.1136/rmdopen‑2021‑002018 35168998
    [Google Scholar]
  5. Linton S. Hossenbaccus L. Ellis A.K. Evidence-based use of antihistamines for treatment of allergic conditions. Ann. Allergy Asthma Immunol. 2023 131 4 412 420 10.1016/j.anai.2023.07.019 37517656
    [Google Scholar]
  6. Chen C. Song X. Murdock D.J. Marcus A. Hussein M. Jalbert J.J. Geba G.P. Association between allergic conditions and COVID-19 susceptibility and outcomes. Ann. Allergy Asthma Immunol. 2024 132 5 637 645.e7 10.1016/j.anai.2024.01.011 38242353
    [Google Scholar]
  7. Sullivan M.O. Curtin M. Flynn R. Cronin C. Mahony J.O. Trujillo J. Telehealth interventions for transition to self‐management in adolescents with allergic conditions: A systematic review. Allergy 2024 79 4 861 883 10.1111/all.15963 38041398
    [Google Scholar]
  8. Račić A. Krajišnik D. Biopolymers in mucoadhesive eye drops for treatment of dry eye and allergic conditions: Application and perspectives. Pharmaceutics 2023 15 2 470 10.3390/pharmaceutics15020470 36839790
    [Google Scholar]
  9. Du M. Xu S. Qiu B. Hu S. Tjakkes G.H.E. Li A. Ge S. Serum antibodies to periodontal pathogens are related to allergic symptoms. J. Periodontol. 2023 94 2 204 216 10.1002/JPER.22‑0346 35960608
    [Google Scholar]
  10. Wang A. Wan P. Hebert J.R. Le Marchand L. Wilkens L.R. Haiman C.A. Atopic allergic conditions and prostate cancer risk and survival in the Multiethnic Cohort study. Br. J. Cancer 2023 129 6 974 981 10.1038/s41416‑023‑02364‑1 37488447
    [Google Scholar]
  11. Moreno C.M. Boeree E. Freitas C.M.T. Weber K.S. Immunomodulatory role of oral microbiota in inflammatory diseases and allergic conditions. Front. Allergy 2023 4 1067483 10.3389/falgy.2023.1067483 36873050
    [Google Scholar]
  12. Singto T. Filor V. Vidak J. Klopfleisch R. Bäumer W. Dendritic cells under allergic condition enhance the activation of pruritogen-responsive neurons via inducing itch receptors in a co-culture study. BMC Immunol. 2024 25 1 17 10.1186/s12865‑024‑00604‑4 38347451
    [Google Scholar]
  13. Ng A. Boersma P. Diagnosed allergic conditions in adults: United States, 2021. NCHS Data Brief 2023 460 1 8 10.15620/cdc:122809 36700875
    [Google Scholar]
  14. Ryan D. Flokstra - de Blok, B.M.J.; Clark, E.; Gaudin, C.; Mamodaly, M.; Kocks, J.; van der Velde, J.L.; Angier, L.; Romberg, K.; Gawlik, R.; Demoly, P.; Tanno, L.K. Allergic and hypersensitivity conditions in non‐specialist care: Flow diagrams to support clinical practice. Allergy 2022 77 9 2618 2633 10.1111/all.15273 35266160
    [Google Scholar]
  15. Jan R.L. Ho C.H. Wang J.J. Tseng S.H. Chang Y.S. A population-based study of sociodemographic factors, associated diseases, and recurrent corneal erosion in Taiwan. Front. Public Health 2022 10 832333 10.3389/fpubh.2022.832333 35419341
    [Google Scholar]
  16. Schellack N. Shirindza N. Mokoena T. Flepisi B. An overview of allergic conjunctivitis. S. Afr. Pharm. J. 2023 90 5 25 29
    [Google Scholar]
  17. Israel A. Schäffer A.A. Berkovitch M. Ozeri D.J. Merzon E. Green I. Golan-Cohen A. Ruppin E. Vinker S. Magen E. Glucose-6-phosphate dehydrogenase deficiency and long-term risk of immune-related disorders. Front. Immunol. 2023 14 1232560 10.3389/fimmu.2023.1232560 37753082
    [Google Scholar]
  18. Ahmad T. Keshari B.B. Sawant V. Saha S. Role of Viruddha Ahara in allergic conditions W.S.R. Veerya Viruddha: An Ayurvedic perspective. World J. Biol. Pharm. Health. Sci. 2022 12 3 186 192 [PMID: Not available
    [Google Scholar]
  19. Chang Y.S. Ho C.H. Wang J.J. Tseng S.H. Jan R.L. The sociodemographic and risk factors for Fuchs’ endothelial dystrophy: A nationwide, matched case–control study in Taiwan. J. Pers. Med. 2022 12 2 305 10.3390/jpm12020305 35207793
    [Google Scholar]
  20. Saeki H. Ohya Y. Nawata H. Arima K. Inukai M. Rossi A.B. Bego-Le-Bagousse G. Impact of the family and household environment on pediatric atopic dermatitis in Japan. J. Clin. Med. 2023 12 8 2988 10.3390/jcm12082988 37109324
    [Google Scholar]
  21. Zhernov Y.V. Simanduyev M.Y. Zaostrovtseva O.K. Semeniako E.E. Kolykhalova K.I. Fadeeva I.A. Kashutina M.I. Vysochanskaya S.O. Belova E.V. Shcherbakov D.V. Sukhov V.A. Sidorova E.A. Mitrokhin O.V. Molecular mechanisms of scombroid food poisoning. Int. J. Mol. Sci. 2023 24 1 809 10.3390/ijms24010809 36614252
    [Google Scholar]
  22. Kumar A. Pramanik J. Goyal N. Chauhan D. Sivamaruthi B.S. Prajapati B.G. Chaiyasut C. Gut microbiota in anxiety and depression: Unveiling the relationships and management options. Pharmaceuticals 2023 16 4 565 10.3390/ph16040565 37111321
    [Google Scholar]
  23. Khan M.T. Dwibedi C. Sundh D. Pradhan M. Kraft J.D. Caesar R. Tremaroli V. Lorentzon M. Bäckhed F. Synergy and oxygen adaptation for development of next-generation probiotics. Nature 2023 620 7973 381 385 10.1038/s41586‑023‑06378‑w 37532933
    [Google Scholar]
  24. Titova N. Probiotics in the treatment and prevention of allergic diseases. Paediatr East Eur 2023 11 3 86 92 [PMID: Not available
    [Google Scholar]
  25. Song M.W. Kim K.T. Paik H.D. Probiotics as a functional health supplement in infant formulas for the improvement of intestinal microflora and immunity. Crit. Rev. Food Sci. Nutr. 2023 63 19 7087 7099
    [Google Scholar]
  26. Tang M. Wang W. Zhang J. Zhu Y. Cao Y. Interaction and mechanism of probiotics with gut flora and immune regulation: A review. Sci. Technol. Food Ind. 2022 43 6 1 14 [PMID: Not available
    [Google Scholar]
  27. Hashemi B. Abdollahi M. Abbaspour-Aghdam S. Hazrati A. Malekpour K. meshgi, S.; Kafil, H.S.; ghazi, F.; Yousefi, M.; Roshangar, L.; Ahmadi, M. The effect of probiotics on immune responses and their therapeutic application: A new treatment option for multiple sclerosis. Biomed. Pharmacother. 2023 159 114195 10.1016/j.biopha.2022.114195 36630847
    [Google Scholar]
  28. Alam Z. Shang X. Effat K. Kanwal F. He X. Li Y. Xu C. Niu W. War A.R. Zhang Y. The potential role of prebiotics, probiotics, and synbiotics in adjuvant cancer therapy especially colorectal cancer. J. Food Biochem. 2022 46 10 e14302 10.1111/jfbc.14302 35816322
    [Google Scholar]
  29. Gocher AM Malhotra A Wang H Goll JB Surendran N Shi L Interferon gamma induction of TH1-like Tregs controls anti-viral responses J. Immunol 2022 208 53.23 S53.23
    [Google Scholar]
  30. Mao R. Wang J. Xu Y. Wang Y. Wu M. Mao L. Chen Y. Li D. Zhang T. Diao E. Chi Z. Wang Y. Chang X. Oral delivery of bi-autoantigens by bacterium-like particles (BLPs) against autoimmune diabetes in NOD mice. Drug Deliv. 2023 30 1 2173339 10.1080/10717544.2023.2173339 36719009
    [Google Scholar]
  31. Su Q. Ren N. Feng M. Zeng X. Dong Y. Xian M. Shi X. Luo T. Liu G. Li J. Specific immunoglobulin G4 correlates with Th2 cytokine reduction in patients with allergic asthma treated by Dermatophagoides pteronyssinus subcutaneous immunotherapy. World Allergy Organ. J. 2023 16 1 100715 10.1016/j.waojou.2022.100715 36820309
    [Google Scholar]
  32. Gomides T.A.R. de Souza M.L.M. de Figueiredo A.B. Lima M.R. Silveira A.M.S. de Assis G.F.M. Fraga L.A.O. Silveira-Nunes G. Martucci L. Garcia J.D. Afonso L.C.C. Teixeira-Carvalho A. Leite P.M. Expression of SmATPDases 1 and 2 in Schistosoma mansoni eggs favours IL ‐10 production in infected individuals. Parasite Immunol. 2024 46 1 e13017 10.1111/pim.13017 37922505
    [Google Scholar]
  33. Ghorban Movahed M. Abdi Ali A. Ghazanfari T. Modaresi M. Cytokine patterns in cystic fibrosis patients with different microbial infections in oropharyngeal samples. Cytokine 2022 160 156038 10.1016/j.cyto.2022.156038 36150317
    [Google Scholar]
  34. Hu J. Chen J. Xu X. Hou Q. Ren J. Yan X. Gut microbiota-derived 3-phenylpropionic acid promotes intestinal epithelial barrier function via AhR signaling. Microbiome 2023 11 1 37 [PMID: 36864529
    [Google Scholar]
  35. Assimakopoulos S.F. Bhagani S. Aggeletopoulou I. Tsounis E.P. Tsochatzis E.A. The role of gut barrier dysfunction in postoperative complications in liver transplantation: pathophysiological and therapeutic considerations. Infection 2024 52 3 723 736 10.1007/s15010‑024‑02182‑4 38324146
    [Google Scholar]
  36. Shi R. Yu F. Hu X. Liu Y. Jin Y. Ren H. Lu S. Guo J. Chang J. Li Y. Liu Z. Wang X. Hu P. Protective effect of Lactiplantibacillus plantarum subsp. plantarum SC-5 on dextran sulfate sodium-induced colitis in mice. Foods 2023 12 4 897 10.3390/foods12040897 36832972
    [Google Scholar]
  37. Olivo-Martínez Y. Bosch M. Badia J. Baldomà L. Modulation of the intestinal barrier integrity and repair by microbiota extracellular vesicles through the differential regulation of trefoil factor 3 in LS174T goblet cells. Nutrients 2023 15 11 2437 10.3390/nu15112437 37299399
    [Google Scholar]
  38. Yuki M. Matsumoto K. Yasuda H. Kato S. Protective role of epithelial TRPV4 in the pathogenesis of OVA-induced food allergy in mice Proc Annu. Meet Jpn Pharmacol. Soc 2022 2 149 10.1254/jpssuppl.95.0_2‑P‑149
    [Google Scholar]
  39. Poto R. Fusco W. Rinninella E. Cintoni M. Kaitsas F. Raoul P. Caruso C. Mele M.C. Varricchi G. Gasbarrini A. Cammarota G. Ianiro G. The role of gut microbiota and leaky gut in the pathogenesis of food allergy. Nutrients 2023 16 1 92 10.3390/nu16010092 38201921
    [Google Scholar]
  40. Wu F. Kong Y. Chen W. Liang D. Xiao Q. Hu L. Tan X. Wei J. Liu Y. Deng X. Liu Z. Chen T. Improvement of vaginal probiotics Lactobacillus crispatus on intrauterine adhesion in mice model and in clinical practice. BMC Microbiol. 2023 23 1 78 10.1186/s12866‑023‑02823‑y 36949381
    [Google Scholar]
  41. Zawistowska-Rojek A. Kośmider A. Stępień K. Tyski S. Adhesion and aggregation properties of Lactobacillaceae strains as protection ways against enteropathogenic bacteria. Arch. Microbiol. 2022 204 5 285 10.1007/s00203‑022‑02889‑8 35478049
    [Google Scholar]
  42. Amiin M.K. Lahay A.F. Putriani R.B. Reza M. Putri S.M.E. Sumon M.A.A. Jamal M.T. Santanumurti M.B. The role of probiotics in vannamei shrimp aquaculture performance: A review. Vet. World 2023 16 3 638 649 10.14202/vetworld.2023.638‑649 37041844
    [Google Scholar]
  43. Xiong R.G. Zhou D.D. Wu S.X. Huang S.Y. Saimaiti A. Yang Z.J. Shang A. Zhao C.N. Gan R.Y. Li H.B. Health benefits and side effects of short-chain fatty acids. Foods 2022 11 18 2863 10.3390/foods11182863 36140990
    [Google Scholar]
  44. Mansuy-Aubert V. Ravussin Y. Short chain fatty acids: The messengers from down below. Front. Neurosci. 2023 17 1197759 10.3389/fnins.2023.1197759 37483350
    [Google Scholar]
  45. Zhang Q. Lu C. Fan W. Zhang J. Yin Y. Application background and mechanism of short-chain fatty acids in sepsis-associated encephalopathy. Front. Cell. Infect. Microbiol. 2023 13 1137161 10.3389/fcimb.2023.1137161 37056708
    [Google Scholar]
  46. Fei Y. Chen Z. Han S. Zhang S. Zhang T. Lu Y. Berglund B. Xiao H. Li L. Yao M. Role of prebiotics in enhancing the function of next-generation probiotics in gut microbiota. Crit. Rev. Food Sci. Nutr. 2023 63 8 1037 1054 10.1080/10408398.2021.1958744 34323634
    [Google Scholar]
  47. Jia B. Zou Y. Han X. Bae J.W. Jeon C.O. Gut microbiome-mediated mechanisms for reducing cholesterol levels: implications for ameliorating cardiovascular disease. Trends Microbiol. 2023 31 1 76 91 10.1016/j.tim.2022.08.003 36008191
    [Google Scholar]
  48. Sionek B. Szydłowska A. Zielińska D. Neffe-Skocińska K. Kołożyn-Krajewska D. Beneficial bacteria isolated from food in relation to the next generation of probiotics. Microorganisms 2023 11 7 1714 10.3390/microorganisms11071714 37512887
    [Google Scholar]
  49. Vallianou N.G. Kounatidis D. Tsilingiris D. Panagopoulos F. Christodoulatos G.S. Evangelopoulos A. Karampela I. Dalamaga M. The role of next-generation probiotics in obesity and obesity-associated disorders: Current knowledge and future perspectives. Int. J. Mol. Sci. 2023 24 7 6755 10.3390/ijms24076755 37047729
    [Google Scholar]
  50. Zhao X. Zhao J. Li D. Yang H. Chen C. Qin M. Wen Z. He Z. Xu L. Akkermansia muciniphila: A potential target and pending issues for oncotherapy. Pharmacol. Res. 2023 196 106916 10.1016/j.phrs.2023.106916 37690533
    [Google Scholar]
  51. Boyte M.E. Benkowski A. Pane M. Shehata H.R. Probiotic and postbiotic analytical methods: A perspective of available enumeration techniques. Front. Microbiol. 2023 14 1304621 10.3389/fmicb.2023.1304621 38192285
    [Google Scholar]
  52. Huang C.H. Huang C-T. Tsai H-Y. Liao Y-C. Lin C-M. Chen P-C. Liou J-S. Hsu C-L. Chiu S-H. Chen C-C. Hsieh S-Y. Zou H-B. Hsu C-C. Chen P-S. Kao C-Y. Ruan J-W. Distinct protective effects of a novel Akkermansia sp. BCRC 18949 against DSS-Induced colitis in mice. J. Funct. Foods 2024 115 106110 10.1016/j.jff.2024.106110
    [Google Scholar]
  53. Torres-Miranda A. Vega-Sagardía M. Garrido D. Intrinsically disordered proteins and their “mysterious” (meta)physics. Encyclopedia of Biomedical Engineering. Amsterdam Elsevier 2019 733 747 10.1016/B978‑0‑12‑819265‑8.00055‑3
    [Google Scholar]
  54. He Z. Wang T. Zhang S. Shi K. Wang F. Li Y. Lin C. Chen J. Evaluation of cholesterol transformation abilities and probiotic properties of Bacteroides dorei YGMCC0564. Front. Microbiol. 2023 14 1279996 10.3389/fmicb.2023.1279996 38029107
    [Google Scholar]
  55. Sadeghi A. Ebrahimi M. Kharazmi M.S. Jafari S.M. Role of nanomaterials in improving the functionality of probiotics; integration of nanotechnology onto micro-structured platforms. Food Biosci. 2023 53 102843 [PMID: Not available]. [http://dx.doi.org/10.1016/j.fbio.2023.102843
    [Google Scholar]
  56. Chernikova D.A. Zhao M.Y. Jacobs J.P. Microbiome therapeutics for food allergy. Nutrients 2022 14 23 5155 10.3390/nu14235155 36501184
    [Google Scholar]
  57. Sindher S.B. Long A. Chin A.R. Hy A. Sampath V. Nadeau K.C. Chinthrajah R.S. Food allergy, mechanisms, diagnosis and treatment: Innovation through a multi‐targeted approach. Allergy 2022 77 10 2937 2948 10.1111/all.15418 35730331
    [Google Scholar]
  58. Wong-Chew R.M. de Castro J.A.A. Morelli L. Perez M. Ozen M. Gut immune homeostasis: The immunomodulatory role of Bacillus clausii, from basic to clinical evidence. Expert Rev. Clin. Immunol. 2022 18 7 717 729 10.1080/1744666X.2022.2085559 35674642
    [Google Scholar]
  59. Lloyd M. Loke P. Ashley S. Lozinsky A.C. Orsini F. O’Sullivan M. Gold M. Quinn P. Metcalfe J. Tang M.L.K. Interaction between baseline participant factors and treatment effects following peanut oral immunotherapy. J. Allergy Clin. Immunol. Pract. 2024 12 4 1019 1028.e2 10.1016/j.jaip.2023.12.028 38154554
    [Google Scholar]
  60. van Amersfort K. van der Lee A. Hagen-Plantinga E. Evidence‐base for the beneficial effect of nutraceuticals in canine dermatological immune‐mediated inflammatory diseases: A literature review. Vet. Dermatol. 2023 34 4 266 283 10.1111/vde.13152
    [Google Scholar]
  61. Gu S. Yang D. Liu C. Xue W. The role of probiotics in prevention and treatment of food allergy. Food Sci. Hum. Wellness 2023 12 3 681 690 [PMID: Not available]. [http://dx.doi.org/10.1016/j.fshw.2022.09.001
    [Google Scholar]
  62. Di Costanzo M. Vella A. Infantino C. Morini R. Bruni S. Esposito S. Biasucci G. Probiotics in infancy and childhood for food allergy prevention and treatment. Nutrients 2024 16 2 297 10.3390/nu16020297 38257190
    [Google Scholar]
  63. Huang Y.Y. Liang Y.T. Wu J.M. Wu W.T. Liu X.T. Ye T.T. Chen X.R. Zeng X.A. Manzoor M.F. Wang L.H. Advances in the study of probiotics for immunomodulation and intervention in food allergy. Molecules 2023 28 3 1242 10.3390/molecules28031242 36770908
    [Google Scholar]
  64. Wei Y. Peng J. Wang S. Ding Z. Chen G. Sun J. Probiotics and the potential of genetic modification as a possible treatment for food allergy. Nutrients 2023 15 19 4159 10.3390/nu15194159 37836443
    [Google Scholar]
  65. Shao H. Min F. Huang M. Wang Z. Bai T. Lin M. Li X. Chen H. Novel perspective on the regulation of food allergy by probiotic: The potential of its structural components. Crit. Rev. Food Sci. Nutr. 2024 64 1 172 186 10.1080/10408398.2022.2105304 35912422
    [Google Scholar]
  66. Vijayan S. Kandi V. Palacholla P.S. Rajendran R. Jarugu C. Ca J. Pravallika M. Reddy S.C. Sucharitha A.S. Probiotics in allergy and immunological diseases: A comprehensive review. Cureus 2024 16 3 e55817 10.7759/cureus.55817 38590477
    [Google Scholar]
  67. Rahman T. Sarwar P.F. Potter C. Comstock S.S. Klepac-Ceraj V. Role of human milk oligosaccharide metabolizing bacteria in the development of atopic dermatitis/eczema. Front Pediatr. 2023 11 1090048 10.3389/fped.2023.1090048 37020647
    [Google Scholar]
  68. Wise S.K. Damask C. Roland L.T. Ebert C. Levy J.M. Lin S. Luong A. Rodriguez K. Sedaghat A.R. Toskala E. Villwock J. Abdullah B. Akdis C. Alt J.A. Ansotegui I.J. Azar A. Baroody F. Benninger M.S. Bernstein J. Brook C. Campbell R. Casale T. Chaaban M.R. Chew F.T. Chambliss J. Cianferoni A. Custovic A. Davis E.M. DelGaudio J.M. Ellis A.K. Flanagan C. Fokkens W.J. Franzese C. Greenhawt M. Gill A. Halderman A. Hohlfeld J.M. Incorvaia C. Joe S.A. Joshi S. Kuruvilla M.E. Kim J. Klein A.M. Krouse H.J. Kuan E.C. Lang D. Larenas-Linnemann D. Laury A.M. Lechner M. Lee S.E. Lee V.S. Loftus P. Marcus S. Marzouk H. Mattos J. McCoul E. Melen E. Mims J.W. Mullol J. Nayak J.V. Oppenheimer J. Orlandi R.R. Phillips K. Platt M. Ramanathan M. Raymond M. Rhee C-S. Reitsma S. Ryan M. Sastre J. Schlosser R.J. Schuman T.A. Shaker M.S. Sheikh A. Smith K.A. Soyka M.B. Takashima M. Tang M. Tantilipikorn P. Taw M.B. Tversky J. Tyler M.A. Veling M.C. Wallace D. Wang D.Y. White A. Zhang L. International consensus statement on allergy and rhinology: Allergic rhinitis – 2023. Int. Forum Allergy Rhinol. 2023 13 4 293 859 10.1002/alr.23090
    [Google Scholar]
  69. Al-Moamary M.S. Alhaider S.A. Allehebi R. Idrees M.M. Zeitouni M.O. Al Ghobain M.O. Alanazi A.F. Al-Harbi A.S. Yousef A.A. Alorainy H.S. Al-Hajjaj M.S. The Saudi initiative for asthma - 2024 update: Guidelines for the diagnosis and management of asthma in adults and children. Ann. Thorac. Med. 2024 19 1 1 55 10.4103/1817‑1737.44776 38444991
    [Google Scholar]
  70. Rojo Gutiérrez M.I. Ballesteros González D. Ortiz Durán A.K. Non-IgE-mediated food allergy. Rev. Alerg. Mex. 2023 70 4 269 279 [PMID: 38506871
    [Google Scholar]
  71. Ridolo E. Incorvaia C. Heffler E. Cavaliere C. Paoletti G. Canonica G.W. The present and future of allergen immunotherapy in personalized medicine. J. Pers. Med. 2022 12 5 774 10.3390/jpm12050774 35629196
    [Google Scholar]
  72. Rossi C.M. Lenti M.V. Di Sabatino A. Adult anaphylaxis: A state-of-the-art review. Eur. J. Intern. Med. 2022 100 5 12 10.1016/j.ejim.2022.03.003 35264295
    [Google Scholar]
  73. Canonica G.W. Varricchi G. Paoletti G. Heffler E. Virchow J.C. Advancing precision medicine in asthma: Evolution of treatment outcomes. J. Allergy Clin. Immunol. 2023 152 4 835 840 10.1016/j.jaci.2023.07.009 37531979
    [Google Scholar]
  74. Carlucci P. Spataro F. Daddato M.F. Paoletti G. Di Bona D. Biologic drugs and allergen immunotherapy: Potential allies. Explor. Asthma Allergy 2023 1 1 126 141 [PMID: Not available]. [http://dx.doi.org/10.37349/eaa.2023.00014
    [Google Scholar]
  75. Krčmová I. Novosad J. Allergen immunotherapy in treating allergic eosinophilic asthma. Vnitr. Lek. 2022 68 8 517 524 10.36290/vnl.2022.110 36575070
    [Google Scholar]
  76. Guilleminault L. Michelet M. Reber L.L. Combining anti-IgE monoclonal antibodies and oral immunotherapy for the treatment of food allergy. Clin. Rev. Allergy Immunol. 2022 62 1 216 231 10.1007/s12016‑021‑08902‑0 34550555
    [Google Scholar]
  77. Díaz Vidal V.C. Gillispie A. Aranda C. Anvari S. Successful elosulfase alfa desensitization protocol in a patient with Morquio A syndrome. Pediatrics 2022 149 2 e2021052648 10.1542/peds.2021‑052648 35059725
    [Google Scholar]
  78. Havrylyuk A. Zubchenko S. Chopyak V. Clinical immunology and allergology as an important component of continuous medical education of doctors. Acta. Medica Leopoliensia 2022 28 3-4 56 71 10.25040/aml2022.3‑4.056
    [Google Scholar]
  79. Varricchi G. Poto R. Covelli B. Di Spigna G. Galdiero M.R. Marone G. Postiglione L. Spadaro G. Gender dimorphism in IgA subclasses in T2-high asthma. Clin. Exp. Med. 2022 23 3 929 941 10.1007/s10238‑022‑00828‑x 35467314
    [Google Scholar]
  80. Parakhina A.I. Parakhina L.I. Troshina D.A. Levina K.E. Pimenova Y.A. Koteneva E.N. Evstropov A.N. Zakharova L.N. Mironov A.Y. Suranova T.G. Sensitivity of pathogenic and opportunistic microorganisms to probiotic strains in the light of personalized probiotic therapy. Epidemiology and Infectious Diseases 2023 27 5 280 289 [PMID: Not available]. [http://dx.doi.org/10.17816/EID117545
    [Google Scholar]
  81. Carr A. Baliga N.S. Diener C. Gibbons S.M. Personalized Clostridioides difficile engraftment risk prediction and probiotic therapy assessment in the human gut. bioRxiv 2023 2023.04.28.538771
    [Google Scholar]
  82. Ting N.L.N. Lau H.C.H. Yu, J. Cancer pharmacomicrobiomics: targeting microbiota to optimise cancer therapy outcomes. Gut 2022 71 7 1412 1425 10.1136/gutjnl‑2021‑326264 35277453
    [Google Scholar]
  83. Osowiecka K. Skrypnik D. Myszkowska-Ryciak J. Assessment of the impact of nutritional intervention with the probiotic Lactiplantibacillus plantarum 299v on nutritional status and quality of life of Hashimoto’s thyroiditis patients—a randomized double-blind study protocol. J. Pers. Med. 2023 13 12 1659 10.3390/jpm13121659 38138886
    [Google Scholar]
  84. Salehi A. Naserzadeh P. Tarighi P. Afjeh-Dana E. Akhshik M. Jafari A. Mackvandi P. Ashtari B. Mozafari M. Fabrication of a microfluidic device for probiotic drug’s dosage screening: Precision Medicine for Breast Cancer Treatment. Transl. Oncol. 2023 34 101674 10.1016/j.tranon.2023.101674 37224765
    [Google Scholar]
  85. da Silva T.F. Glória R.A. Americo M.F. Freitas A.S. de Jesus L.C.L. Barroso F.A.L. Laguna J.G. Coelho-Rocha N.D. Tavares L.M. le Loir Y. Jan G. Guédon É. Azevedo V.A.C. Unlocking the potential of probiotics: A comprehensive review on research, production, and regulation of probiotics. Probiotics Antimicrob. Proteins 2024 16 5 1687 1723 10.1007/s12602‑024‑10247‑x 38539008
    [Google Scholar]
  86. Quaranta G. Guarnaccia A. Fancello G. Agrillo C. Iannarelli F. Sanguinetti M. Masucci L. Fecal microbiota transplantation and other gut microbiota manipulation strategies. Microorganisms 2022 10 12 2424 10.3390/microorganisms10122424 36557677
    [Google Scholar]
  87. Klimov N.A. Shamova O.V. Microbiota disorders in bacterial vaginosis and the possibility of personalized therapy of the disease with the use of probiotics.(review). Russian J. Personal Med. 2023 2 6 78 90 10.18705/2782‑3806‑2022‑2‑6‑78‑90
    [Google Scholar]
  88. D’Amico F. Barone M. Tavella T. Rampelli S. Brigidi P. Turroni S. Host microbiomes in tumor precision medicine: How far are we? Curr. Med. Chem. 2022 29 18 3202 3230 10.2174/0929867329666220105121754 34986765
    [Google Scholar]
  89. Saleem M. Singh A. Rana V. Probiotics unveiling the microbial allies in human health and beyond. Int. J. Sci. Res. Eng. Manag. 2023 7 11 1 11 [PMID: Not available]. [http://dx.doi.org/10.55041/IJSREM27085
    [Google Scholar]
  90. Amenyogbe E. Application of probiotics for sustainable and environment-friendly aquaculture management - A review. Environ. Sci. Pollut. Res. Int. 2023 30 18 53549 53561
    [Google Scholar]
  91. Li S. Liu Y. Hao W. Wang Y. Ding H. Innovative beverage creation through symbiotic microbial communities inspired by traditional fermented beverages: Current status, challenges and future directions. Crit. Rev. Food Sci. Nutr. 2023 63 19 7100 7118 [PMID: 37357963
    [Google Scholar]
  92. Hussain S.M. Bano A.A. Ali S. Rizwan M. Adrees M. Zahoor A.F. Sarker P.K. Hussain M. Arsalan M.Z.H. Yong J.W.H. Naeem A. Substitution of fishmeal: Highlights of potential plant protein sources for aquaculture sustainability. Heliyon 2024 10 4 e26573 10.1016/j.heliyon.2024.e26573 38434023
    [Google Scholar]
  93. Lloyd M. Loke P. Ashley S. Lozinsky A. Orsini F. Gold M. O’Sullivan M. Prescott S. Allen K. Pitkin S. Axelrad C. Tey D. Robinson M. Su E.L. Metcalfe J. Galvin A.D. Tang M. Health-related quality of life outcomes in a Phase 2b Randomized Trial evaluating the effectiveness and safety of Probiotic Peanut Oral Immunotherapy. J. Allergy Clin. Immunol. 2022 149 2 AB317 10.1016/j.jaci.2021.12.017 36075321
    [Google Scholar]
  94. Butt U.D. Khan S. Liu X. Sharma A. Zhang X. Wu B. Present status, limitations, and prospects of using Streptomyces bacteria as a potential probiotic agent in aquaculture. Probiotics Antimicrob. Proteins 2024 16 2 426 442 10.1007/s12602‑023‑10053‑x 36933159
    [Google Scholar]
  95. Nezamdoost-Sani N. Khaledabad M.A. Amiri S. Mousavi Khaneghah A. Alginate and derivatives hydrogels in encapsulation of probiotic bacteria: An updated review. Food Biosci. 2023 52 102433 10.1016/j.fbio.2023.102433 [PMID: Not available].
    [Google Scholar]
  96. Ardini A Parirska D Lestari S. Penambahan Probiotik Herbal dengan Dosis yang Berbeda terhadap Respon Stres Benih Ikan Gabus. J. Ilm Pertan dan Peternak 2024 1 2 1 10
    [Google Scholar]
  97. Miller B.C. Mathai M. Yadav H. Jain S. Geroprotective potential of microbiome modulators in the Caenorhabditis elegans model. Geroscience 2023 46 1 129 151 10.1007/s11357‑023‑00901‑7 37561384
    [Google Scholar]
  98. Mu J. Guo X. Zhou Y. Cao G. The effects of probiotics/synbiotics on glucose and lipid metabolism in women with gestational diabetes mellitus: A meta-analysis of randomized controlled trials. Nutrients 2023 15 6 1375 10.3390/nu15061375 36986107
    [Google Scholar]
  99. Éliás A.J. Barna V. Patoni C. Demeter D. Veres D.S. Bunduc S. Erőss B. Hegyi P. Földvári-Nagy L. Lenti K. Probiotic supplementation during antibiotic treatment is unjustified in maintaining the gut microbiome diversity: a systematic review and meta-analysis. BMC Med. 2023 21 1 262 10.1186/s12916‑023‑02961‑0 37468916
    [Google Scholar]
  100. Paul C. Mishu I.D. Miah M.I. Bari M.L. Rahman S.R. Malek M.A. Isolation, identification and probiotic potential of lactic acid bacteria and yeasts from commercial yogurt and homemade non-dairy fermented food “KANJI”. Int. J. Gastron. Food Sci. 2023 34 100787 [PMID: Not available]. [http://dx.doi.org/10.1016/j.ijgfs.2023.100787
    [Google Scholar]
  101. Chaiyasut C. Sivamaruthi B.S. Lailerd N. Sirilun S. Thangaleela S. Khongtan S. Bharathi M. Kesika P. Saelee M. Choeisoongnern T. Fukngoen P. Peerajan S. Sittiprapaporn P. Influence of Bifidobacterium breve on the glycaemic control, lipid profile and microbiome of type 2 diabetic subjects: A preliminary randomized clinical trial. Pharmaceuticals 2023 16 5 695 10.3390/ph16050695 37242478
    [Google Scholar]
  102. Fredua-Agyeman M. Stapleton P. Gaisford S. Growth assessment of mixed cultures of probiotics and common pathogens. Anaerobe 2023 84 102790 10.1016/j.anaerobe.2023.102790 39492420
    [Google Scholar]
  103. Debnath N. Yadav P. Mehta P.K. Gupta P. Kumar D. Kumar A. Gautam V. Yadav A.K. Designer probiotics: Opening the new horizon in diagnosis and prevention of human diseases. Biotechnol. Bioeng. 2024 121 1 100 117 10.1002/bit.28574 37881101
    [Google Scholar]
/content/journals/aiaamc/10.2174/0118715230407403251105101126
Loading
Next-Generation Probiotics in Allergy Therapy: Scientific Evidence and Clinical Applications
Bentham Science Publishers ; https://doi.org/10.2174/0118715230407403251105101126
/content/journals/aiaamc/10.2174/0118715230407403251105101126
/content/journals/aiaamc/10.2174/0118715230407403251105101126
Loading

Data & Media loading...


  • Article Type:     Review Article
Keywords: next-generation probiotics ; gut microbiome ; allergy therapy ; regulatory T cells ; immune modulation ; personalized medicine ; microbiome sequencing ; Allergic diseases

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test